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The chief objective of this paper is to review all the sig-
nificant literature pertaining to inaulin~secreting tumors of the 
isleta of Langerhans. In 1950, Howard and his associates collected 
and tabulated all documented cases until that time. Therefore, 
unless individual case reports published prior to the appearance 
of the Howard paper are especially contribut~ve to an understanding 
of the subject, they have been excluded from reference here. There 
were, of course, several papers which analyzed such things as patho-
logy, pathogenesis of symptoms, and diagnosis prior to 1950 and 
had much to say. These are dealt with. 
" 
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I. INTRODUCTION 
Islet cell adenomas are benign neoplasms of the islets of Lan-
gerhans. Some produce insulin, while others do not. Each category 
has its malignant counterpart. We are hera considering the functional 
tumors (insulinomas, nesidioblastamas), which secrete abnormally 
large quantities of insulin and give rise to a clinical syndrome the 
manifestations of which are predominantly neurologic. The etiology 
is, as yet, unknown. 
II. HISTORY 
In 1869, Langerhans discovered the pancreatic tissue which 
bears his name. Nicholls (64), in 1901, discovered, at necropsy, a 
tumor of that tissue but gave no clinical history of the patient har-
boring it. Soon after the momentous discovery of the endocrinolo-
gical function of the islets of Langerhane by Banting and Best in 
1922 (31), the symptoms of insulin overdosage were observed (49). 
Seale Harris (35), in 1924, theorized the possibility of a tumor of 
the islets which secreted insulin and produced the same symptoms as 
exogenous overdosage. He was proven correct when, in 1927, Wilder 
and associates (92) reported the case of a forty-year-old physician 
who had, at operation, a carcinoma of the islets which had metas-
tasized to the liver. A nodule in the liver was assayed for insulin 
and had several times the usual islet tissue content. In 1929, Ros-
coe Graham effected the first surgical cure by removing a benign 
insulinoma (47). 
Whipple and Frantz (91) reviewed 75 cases from the literature 
and added 6 of their own in 1935. Lopez-Kruger and Dockerty (55) 
reported a total of 137 tumors (16 malignant) including 26 (4 malig-
nant) from the files of the MayoClinic in 1947. Crain and Thorn (24), 
I __ -~ -: . ·~y 
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in 1949, were able to collect 258 cases from the literature. In 
1950, Howard and co-workers (46), in a comprehensive analysis of 
all reported cases, listed 264 instances from the world literature,. 
among a total of 398 including both functioning and non-functioning 
lesions. Since 1950, many more have been documented. 
III:. PATHOLOGY 
The insulinoma is a rare tumor. Of 10,314 autopsies at the 
Mayo Clinic (55), 44 tumors were found, of which only 8 were "func-
tioning." Pease (55) was said to have found 8 tumors in 500 consecu-
tive autopsies, of which 2 were pea-sized and 6 microscopic, which 
suggests that a higher incidence might be seen if they were diligent-
ly sought. 
Inaulinomas have been found among people of all age groups, the 
extremes being a one-day old infant (78) and a patient of sixty-nine 
(95). Th~is a preponderance in the fourth and fifth decades, the 
mean age in one large series being 41.5 years (55). The more h!.atc:a~-..J,; 
logically beni99 the tumor, the older the peak of incidence, with 
metastatic carcinoma tending to appear in the fourth decade (55). 
Furthermore a large difference exists between the functioning and 
non-functioning tumors with respect to age, since the peak of inci-
dence in the latter group begins past the middle of the sixth decade 
(55). Clearly, however, no age group can be excluded from consi-
deration of the diagnosis when the eigne and symptoms present them-
selves. 
Males and females have an approximately equal chance of having 
the tumor (24, 46, 55). In the group of metastatic lesions, a slight 
male-female differe~ce is note1, 15 of 24 in Crain and Thorn's series 
being in males. 
Tumor size is variable, ranging from microscopic to 11 centime-
ters at its greatest diameter (24). However, the vast majority ap-
pear to be within one and three centimeters, a size small enough to 
elude the surgeon's palpating finger (e.g. 16). 
The occurrence of multiple tumors is not unknown (46). Of 159 
beni;s adenomas removed at operation, 11.3 per cent of the patients 
had multiple tumors. Fourteen and three tenths per cent of benign 
insulinomas found at autopsy were in patients with multiple tumors. 
Of the suspiciously malignant group 12 to 14 per cent had multiple 
tumors (46). Several reports are on record of the occurrence of ade-
nomatosis of the pancreas (6, 33, 24} and there is also documentation 
of multiple endocrine adenomas associated with insulinoma (24, 62, 
86}. 
In Crain and Thorn's series, there were 67 of 238 benign adenomas 
found in the head of the pancreas and 2 of 20 malignant tumors in the 
head. A total of 7 tumors were found in aberrant locations outside 
the pancreas. On perusing the literature one has the impression that 
since this report many of tre published cases were of tumors in the 
head of the organ (7, 8~ 9, 15, 26, 32, 57), yet some authors assume 
this to be a rare location. Since a l•rger percentage are located 
outside the head, there is some justification for »blind» resection 
of the body and tail when no tumor is found at operation. 
Macroscopically, the tumors have been described as pink to 
purplish (30), grayish white or yellowish (84). Their consistency 
varies from the same as the pancreas to firm (84) and they are sel-
dom detected on the surface of the organ. Lose of the normal pan-
creatic lobulation is the most consistent change indicatingsthe pre-
sence of tumor (84). Most of the tumors located in the head are 
situated deep within the parenchyma, out of range of palpation, 
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while those in the body and tail are easier to find. 
Microscopically, the tumors tend to preserve the architecture 
of their normal forebears. The arrangement of cells is variable and 
tends to be in ribbons, sheets, anastomosing cords, and solid clumps 
(30, 46, 84). Sometimes fibrous tissue or normal acini are trapped 
in th• tumor, but they are generally all islet tissue with scant 
stroma. 
The tumor cells vary from small and round to columnar, often 
arranged in ribbons one or two cells thick, with their long axis 
perpendicular to the basement membrane. The nuclei are usually small 
and contain one or two nucleoli, but few or no mitotic figures (84). 
Except in columnar-cell arrangements, the cytoplasm is scanty. The 
vascularity varies considerably, but the observation has been made 
" that the cells appear to be bathed directly in blood without any in-
tervening endothelium (65, 84). This was said to be untrue of the 
non-functioning islet cell adenoma. Some have been able to demons-
trate beta granules in the cytoplasm of the cells (63), while others 
have not (82). The presence of beta granules in a inaulinoma is 
said to be an index of function (63), especially if they are not 
demonstrable in the normal islet tissue. 
Lopez-Kruger and Dockerty (57) use the following classification 
of islet cell adenomas: 
(1) Adenomas of islet cells without hypoglycemia 
(2) Ademomas of islet cells with hyperinsulinism (3) Metastasizing carcinomas of islet cells without hypoglycemia (4) Metastasizing carcinomas of islet cells with hyperinsulinism (5) Borderline malignant islet cell tumors with or without hyper-
insulinism 
The reason for such a classification is that, thus far, there is no 
conclusive evidence that a benigB adenoma is subject to malignant de-
generation and that, consequently, the only absolute evidence of ma-
lignancy is metastasis. Tumors which have shown microscopic evidence 
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of what one would call malignancy ware he dealing, say, with an ade-
nocarcinoma of the colon, have bean enucleated without recurrence by 
many surgeons. Furthermore, in no case has an adenoma, once excised, 
aver bean followed by the appearance of metastasis (46). 
Attempts are made to show a distinction histologically, to wit 
the following list of differences between benign and malignant ade-
nomas (55): 
(1) 
(2) 
(3) (4) 
(5) 
The occurrence of mitoses, in numbers up to 5 par high power 
field 
The presence of atypical mitoses, soma of giant or otherwise 
bizarre configuration 
The presence of large nucleoli in almost all the tumor cells 
Invasion of large or small vascular and lymphatic channels in 
avery instance 
The occurrence of necrosis and hemorrhage 
These are characteristics of tumors which have metastasized. Of them-
selves, they are superfluous since the malignant natura of the tumor 
is obvious. When the attempt is made to modify these characteris-
tics and apply them to the Hbordarline malignantH category, some dif-
ficulty is encountered. These were said to be larger than the benign 
variety, with 10 of 37 showing gross invasion of surrounding tissue 
and histological characteristics generally similar to:; the metastatic 
group in a lesser degree, e.g. nucleoli prominent but the ~ird-eyeH 
variety rarely observed. Venous invasion was also noted. Lopez-
Kruger and Dockerty feel that " •••• venous invasion in any islet call 
tumor and cytologic evidence of malignancy greater than 1 (Broders) 
are at present the most important microscopic indexes we have by way 
of correlating the histologic appearance of the tumor and ita metas-
tasizing capabilities ... The surgical need for a means of differen-
tiating the benignancy or malignancy of a tumor is obvious, yet evi-
dence opposed the the Mayo Clinic report exists, e.g. venous and 
lymphatic invasion and incomplete capsula (50% of Crain and Thorn's 
aeries) have been repeatedly observed. Grading of malignancy with 
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~ the Broders classification is seldom reported. As of now, the dif-
ferentiation cannot be made with assurance. Clinical behavior of 
insulinomas may give a hint of the nature, as will be discussed 
below. 
Metastases, when they occur, llaJ 'be'-<found in almost any body 
tissue, the vast majority showing up in the regional lymph nodes and/ 
or the liver (24). 
It is of some interest that, to date, fifteen cases of tumors 
which secrete a substance which lowers the blood sugar in insulin-
like fashion and give rise to a syndrome identical with that asso-
ciated with islet cell adenoma have been reported (2) (The bearing 
of this fact on cases in which no insulinoma is found either in the 
pancreas or its common aberrant locations is evident) In four cases 
(80) an adrenal tumor has been reported in association with hypogly-
cemic episodes. Other features accompanied two of these tumors, one 
a Cushing-like syndrome and the other 1 virilism. Adrenal failure was 
not implicated as causative of the hypoglycemia, rather it was attri-
buted to some substance secreted by the tumors. In 2 of the 4 cases, 
the disturbances were confirmed as hypoglycemic in origin because of 
low blood sugar determinations. This essential laboratory data was 
missing in the athers. 
IV. PATHOGENESIS OF SYMPTOMS 
The characteristic symptomatology of insulinoma occurs during 
periods of fast and vigorous exercise predominantly (23). It is 
promptly relieves by the administration of carbohydrate. Patients 
tend to carry candy with them to abort attacks. 
Why the pituitary-adrenocortical axis fails to support the 
blood glucose level when hyperinsulinism drops it is a mystery. 
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Why exogenously administered ACTH will stop an attack, yet the same 
amount, .which Burne' experiments (14) suggest could be secreted by 
the human pituitary, is not secreted within the body is also a mys-
tery. Possibly a state of hypercorticalism is too much in exchange. 
Possibly, at first the adrenals do respond to the need, but soon are 
overworked and fail to secrete the amount required (49). Hyperpla-
sia of the adrsnals has been seen at necropsy in patients with insu-
linoma, suggesting that some attempt is made, although anatomical 
findings are no guaranteed concomitant of an inferred state of func-
tion. Adenomas have also been noted in the adenohypophysis (as have 
adenomas of the parathyroids) (86). Again, however, too few cases 
of adrenal pathology have been found associated with ineulinomaa to 
draw any conclusions. What part the endocrine system played in the 
five cases of hypoglycemic episodes associated with the mensas (88) 
which have bean reported is unknown. 
Whatever the case of hypoglycemia, its clinical manifestations 
are referable mainly to the central nervous system, although the 
gastrointestinal (36, 12) and cardiovascular (37, 89) systems are 
also sometimes affected. 
The brain has a respiratory quotient of .98 to 1.00 (43), indi-
cating that it utilizes for energy requirements carbohydrate almost 
exclusively. Oxygen is, of course, also required. Himw1ch and his 
associates experimented with schizophrenic patients undergoing insu-
lin shock therapy and showed that a lower arteriovenous oxygen dif~ 
ference could be demonstrated during coma (4o). It could not be at-
tributed to an increased blood flow, which aetually fell during coma, 
but must have been due t~ a diminished brain metabolism. In furthur 
work (39), the same investigators showed that cerebral metabolism 
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during hypoglycemia may be reduced to about i its prehypoglycemic 
level. The injection of glucose, furthermore, causes the arterio-
venous oxygen difference to rise, which suggests an increase in ce-
rebral metabolic rate corresponding to the greater availability of 
glucose. 
Studies with the brains of people who have dies in profound 
hypoglycemia tend to verify that resultant lesions are of an anoxic 
nature (46, 53). Yannet's studies (97) of the electrolyte compart-
ments of eat's brains subjected to hypoglycemia show profound changea 
in the locus of water, probably the result of tissue damage from 
anoxia. Moreover, during insulin-induced hypoglycemia, electrical 
potentials indicating depression of cerebral activity coincide with 
decrease in oxygen consumption (41). The weight of evidence tends to 
indicate that the lowering of blood glucose interferes with cerebral 
function by preventing the brain from utilizing oxygen. 
The symptoms of hypoglycemia are manifested in different in-
dividuals at different levels of blood glucose. Thus, one person) 
may be in profound coma with a level of barely below 50 milligrams 
per cent, while another may be nearly normal with a level much lo-
wer. One theory which tries to explain this phenomenon (24, 56) 
postulates that the production of symptoms ie tied not to the abso-
lute level of glucose, but its rate of fall. If the rate of fall 
is great, the stimulus to epinephrine secretion is great and the 
symptoms which result are mild and attributable to it: swea\lng, 
tachyeardia.,~·waakna,sFhung~r.· :.If' the rate of fall is small, the 
stimulus is not as great and "cerebral" symptoms dominate the pic-
~ ture: headabbe, visual disturbances, mental confusion, convulsion, 
coma. All intermediate states are possible. 
Fabrykant and Bruger have published an excellent critique of 
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pathogenesis (31). To account for the appearance of symptoms of 
different patients at different levels, they feel that too much em-
phasis has been placed on the ~umption that the uptake of glucose 
by the brain is directly controlled by the level of glucose in the 
blood. It may well be that the decrease in blood sugar does not 
necessarily mean a decrease in brain sugar and that a low blood sugar 
level does not necessarily affect a brain whose metabolic require-
mente are themselves reduced. The development of hypoglycemia sy~ 
toms may there-fore occur (a) When the decrease in blood sugar is 
very profound and cannot be overcome by an increased cerebral glu-
cose consumptions, (b) When the transfer of glucose from the blood 
to the brain is appreciably reduced and (c) When the brain tissue is 
unable to absorb adequate amounts of sugar or to utilize it proper-
" ly even though the sugar may be supplied to it at a normal rate. In 
every one of these instances, the glucose consumption of the brain 
would be reduced below metabolic needs. Such a disturbance may then 
lead to the development of hypoglycemic symptoms by interference 
with the cerebral consumption of oxygen, by disturbance of the meta-
bolism of acetylcholine (a substance which has had some comment as~ 
convulsant substance in hyperinsulinism), or possibly by a still 
unfathomed mechanism. Kety and others (51) have shown that the brain 
uses up its glycog•• reserve after about an hour of severe hypogly-
cemia and that damage becomes increasingly likely thereafter. ~er­
haps variations in the glycogen reaerve of different brains may ex-
plain the differential time of symptom-development among<:pa tients. 
Gastrointestinal manifestations of hyperinsulinism have been 
" usually hunger and pain (12, 24). The hypoglycemic stimulus to vagal 
activity may account for these symptoms. It is remarkable that to 
date only two instances of the coexistence of ulcer and insulinoma 
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have been reported (25, 48). Possibly the intermittent nature of the 
hypoglycemic periods may to soma extent mitigate the effect of vagal 
stimulation. 
Taere is not much mention of cardiovascular manifestations of 
hyperinsulinism in the literature, except that of tachycardia and 
palpitation. One report emphasizes, however, that angina pectoris 
may occur (89), another attributes a coronary thrombosis to the ef-
fects of hypoglycemia (71), and Harrison (37) says that "the circu-
latory manifestations of relative hypoglycemia are the same as those 
observed after the experimental or therapeutic administration of in-
sulin. They appear to be related to two mechanisms: release of epi-
nephrine, and alterations comparable to those which occur in anoxia. 
The increased venous return so brought about, causae an augmented 
cardiac output and the typical eigne of 'the overactive heart'." 
V. THE HISTORY 
A list of the eigne and symptoms of hyperinsulinism, such as 
has been published by Crain and Thorn (24), can be deceptive, for 
while the number and variety is undoubtedly large, exactly what neu-
rologic symptom is exhibited is much less important than the pattern 
of a ttacke. ..\S Conn and Seltzer ( 23) rightly emphasize, '' ••• , perio-
dicity of symptomatology represents a more important diagnostic hint 
of underlying hypoglycemia than the specific type of complaint which 
is offered." 
Typically, then, the patient gives a history of repeated epi-
sodes occurring before breakfast, occasionally prior to the noon 
meal, or whenever a meal ie skipped. They have quickly learn• that 
sweetened tea or coffee, candy, orange juice, or other carbohydrate 
intake will abort such episodes and the habit of supplementary fee-
" 
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dings is often acquired. symptoms may have been present for weeks to 
years before a physician is consulted. These patients have become 
concerned either because they have experienced an increase in the 
frequency (4, 6, 15! or severity (7, 8, 9) of their symptoms, many 
of them having been in coma when they arrive at the hospital (1, 
47, 88), exhibited an outbreak of apparently psychotic behavior (9, 
83), or had one or more convulsions (66, 78). If one is not aware 
of the possibility of an insulinoma, a diagnostic tragedy may then 
ensue. Such diagnoses as (24) epilepsy, narcolepsy, intracranial 
tumor, diffuse disease of the brain or spinal cord, psychosE, psycho-
neurosis, neurasthenia, hysterical amnesia, anxiety states with 
conversion symptoms (21), catatonic schizophrenia (56), or drunkenesa 
(34) have been made. 
It may be of some interest to riote the percentage of cases in 
which various symptoms have been exhibited, Crain and Thorn's t24) 
analysis of 193 well-documented patients with tneulinoma yielded a 
list which may be weighted in favor of the more spectacular symptoms, 
because the history was taken generally before surgery. 
Symptom £!: Sign l!.!: Q!9! 
1. Loss of consciousness 58 
2. Confusional state 54 
3. Weakness and fatigue 41 
4. Deep coma 40 
5. Sweating 36 
6. Drowsiness and stupor 35 
7. Lightheadednesa 30 
8. Visual disturbances 30 
9. Amnesia 28 
10. Clonic convulsions 24 
11. Noisy behavior 20 
12. He:J.dache 20 
13. Tr~mcr 18 
14. Hun~!!'r 14 
15. Positive Babinski 13 
16. Paresthesiae 13 
17. Irritability ll 
18. Transient hemiplegia 10 
19. Abdominal pain 8 
20. Palpitation 3 
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Duration of these symptoms varied between 2 weeks and 20 yaare 
b•fore surgery. Twenty-five per cent had symptoms lasting over 5 
years. Only 3 of the group of 24 malignant insulinomas had given 
rise to symptoms for over 2 years. Deep coma was seen in 95 per cent 
with metastatic lesions as opposed to only one third with benign 
lesions. This may be partly explainable on the basis of a lose of 
liver parenchymal glycogen supplies resulting from metastases. 
seven of 12 patients thought to have irreversible personality 
changes with mental deterioration were restored completely to nor-
mal after a successful operation. 
The occurrence in 10 per cent of patients of hemiparesis is 
important. Ordinarily one immediately thinks of some cerebral vas-
cular lesion or unilateral tumor as the moat likely possibility and 
" might tend to overlook a disorder of metabolism such as hyperinsu-
linism. One case of a 12 hour, spontaneously resolving, flaccid 
quadriplegia has been seen (18). 
During the past few years, reports have been made of a syndrome 
resembling progres~iv• muscular atrophy associated with insulinomas. 
Barris (4) reviewed four cases and added one of his own in which 
progressive generalized muscle wasting, muscle fasciculations, in-
creased myotatic irritability, and progressive motor disability were 
seen. In 4 of these cases arrest of the symptoms followed excision 
of the tumor, while in the other it was not found until necropsy, 
when there was also histological evidence of widespread and severe 
- de«eneration of the anterior horn cells of the spinal cord. Lidz 
~ 
and coworkers (54) reported a bizarre case in which muscle atrophy 
was present and disappeared after successful surgery. Roxburgh (76) 
observed wasting of small hand muscles in a 5t year old child. Tom 
and Richardson (85) saw a case, undiagnosed in life, with severe 
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muscle atrophy of the le!s accompanied by histological evidence of 
anterior horn cell destruction. Williams (94) saw a 28 year old man 
in whGm~:the musculature of both shoulders and upper arms was some-
what wasted. Both hands showed marked wasting of the intrinsic mu-
scles, interossei and hypothenar groups in particular. There was 
symmetrical wasting of both quadriceps (with marked faec!?culation 
and fibrillation). Documented cases of this kind suggest hypogly-
cemic damage to the spinal cord similar to that of the brain. Al-
thou!h one may theorize as to their connection with progressive 
muscular atrophy, no conclusions are warranted as yet. 
VI. DIAGNOSIS 
One or more of the following criteria have, in the past, been 
used in the diagnosis of insulinoma (18): 
1. Clinical 
a. Hypoglycemia episodes progressive in frequency and severity 
b. Progressive neurologic symptoms (almost every clinical neu-
rological symptom, diffuse or local, has been described in 
hypoglycemia) 
c. Prebreakfast attacks 
d • .Att·acks if meals are omitted 
e. Obesity 
f. Relief of symptomatology following glucose administration 
g. Response to a high protein, low carbohydrate diet 
2. Laboratory 
a. Repeated low fasting blood sugars (lese than 50 milligrams 
per cent by Folin-Wu method) 
b. Low blood sugar and/pr symptoms after a 24 hour fast 
c. Abnormal glucose tolerance teat 
d. Abnormal insulin tolerance test 
e. Abnormal epinephrine tolerance. test 
f. Liver battery 
g. Assessment of pituitary-adrenal axis 
h. Electroencephalographic findings 
It is obvious that there has been no perfect method of diagnosis. 
OUt of the criteria above, Whipple's triad nas been repeatedly 
called the best group of criteria by which to make the diagnosis (92). 
It consists of (1) repeated episodic disorders referable to the 
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central nervous, gastrointestinal, or cardiovascular system; (2) 
fasting blood sugar levels of less than 50 milligrams per cant; and 
(3) relief of episodes by the administration of glucose. Some have 
thought that, in addition, the patient should have been in good 
health and without disease of the autonomic nervous system prior ro 
the first episode. Whipple himself (90) claims to have made the cor-
rect diagnosis in 34 of a series of 39 cases of hie own. Crain and 
Thorn (24) call it the "sins qua non" of the •diagnosis. 
Fulfillment of the Whipple triad tells us that the patient is 
subject to profound, recurrent hypoglycemia and very little more. 
Functional hypoglycemia, which, with ineulinoma, is said to make up 
80 to 90 per cant of the casas of hypoglycemia, may occur 2 to 4 
hours post-prandially (21), as may the episodes of hyperinsulinism 
of organic causa. Hepatic disease may give rise to a syndrome which 
occurs before breakfast, as may inaulinoma. 
The glucose tolerance teat has bean the subject of controversy. 
It has bean performed in a number of ways. Doses, route of adminis-
tration, and timing of the test vary (18, 77) and this tends to mi-
litate against its standardization in insulinqma and therefore re-
duces its usefulness. Because of its ~pparant inconsistencies it 
has bean called useless by soma (24, 81). All types of curves have 
bean reported. They seam, however, to fall into 2 main categories 
(25) despite all variations in technique. There is the high-plateau 
type, characteristic of diabetics, and the type which, from a subnor-
mal fasting level, rises into the normoglycsmic range, subsequently 
returning to subnormal (16, 25). The latter curve may actually be 
characteristic for hyperinsulinism of organic cause. Conn's 4xhorta~ 
tion (22) that a three-day preparatory period be employed during 
which high carbohydrate amounts are ingested may standardize the re-
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sults to some extent. His reasoning stems from the fact that during 
low carbohydrate intake the organism seems to lose its ability to 
handle glucose efficiently. Apparently when a charge dose is adminis-
tered after a period of relative carbohydrate starvation, blood level• 
become extremely high and glucose may spill into the urine in other-
wise normal subjects. Perhaps this accounts of some of the diabetic 
curves that have been observed. However, ths fact that patients who 
experience episodes pf hypoglycemia tend to increase their uptake of 
carbohydrate argues against this reasoning to account for diabetic 
curves. 
A relatively recent variation on the glucose-tolerance theme is 
the "glucose-assimilation coefficient." By a mathematical analysis 
of the intravenous glucose-tolerance curve (.33 grams/kilo) Conard 
\ 
and others ( 19) have worked out:.: a formula. After the rapid injection 
of glucose intravenously, the blood glucose level at first rises 
sharply and then falls abruptly. This phenomenon is regulated by the 
diffusion of injected glucose through the extracellular fluids. From 
the tenth to the sixtieth minute after the glucose injection, the blood 
laval falls more slowly, following an exponential curve. The slope 
of this curve is easily calculated and is considered a measure of 
the speed with which the body clears the blood of glucose, the "glu-
cose-assimilation coefficient." Normal range is 1.80tO.l6, while 
elderly p:eople avers.ge 0. 99t. 30 ( 17). Non-treated diabetic a have 
a ver~ low figure, 0.5010.20. In Cleempoel et al. 'a 78 year old female 
with islet cell carcinoma, the figure was 3.22, indicating a very 
fast uptake of glucose. This test appears quite logical, but its 
ultimate value must await furthur experience. 
The insulin-sensitivity test has been used in a few instances, 
but the results have been inconsistent. Some have thought very lit-
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tle of its usefulness (28, 52). In any case, no conclusions about 
its value can be drawn at this time. 
Some investigators think that the best way to diagnose organic 
hyperinsulinism is to subject the patient to conditions which will 
reproduce the symptoms (23~ 69). Conn and Seltzer (23), as an ini-
tial approach to suspicious patients give a provocative carbohydrate-
protein diet for three days. The patient is hospitalized and a daily 
fasting blood sugar determination is made. If an insulinoma is pre-
sent the diagnosis is ordinarily clear by the time 48 hours have 
elapsed. When the diagnostic hypoglycemia is not evident after 3 
days on the provocative diet, the patiant is fasted on the fourth day. 
This is followed a by 2 hours of vigorous exercise on a stationary 
bicycle on the morning Of the fifth day with the patient still fasting. 
When they fail to show a f!ating hypoglycemia with the three day pro-
vocative diet, they also failed subsequently. The authors believe, 
however, that the entire procedure should be done for certainty's 
sake. Since in functional hypoglycemia one does not usually see a 
subnormal fasting blood su~ar, but a rebound reaction 2 or 3 hours 
after a la.rge carbohydrate meal, low fasting blood sugars would tend 
to rule this out (unless the two conditione coexist). But in hepa-
tic disease, the reproduction of symptoms as suggested by CQnn and 
Seltzer would tend to be effected. The use of liver function stu-
dies in this regard would be important, as would the physical exami-
nation, which is usually unremarkable between attacks of organic 
hyperinsulinism. In carcinoma, liver metastases would tend to exhi-
bit evidence of the combination of organic hyperinsulinism and hea 
patic glycogen deficiency. 
W~ile it is true that electroencephalographic studies have not 
been diagnostic, they almost al•ays show high voltage, slow activity 
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in the fasting state or with hyperventilation and with a return toward 
normal followin~ glucose adminiatration (24). In some patients a 
spike-and-dome pattern has been found; in some a tendency tD lo-
calization; in others occasional bursts of rapid activity. Smith 
and Cochran (83) report an EEG during the hypoglycemic phase showing a 
well-marked dysrhythmia, consisting of irregular slow activity which 
was sometimes paroxysmal. Whipple(90) says that the normal alpha 
rhythm of 8 to 10 cycles par second decreases as hypoglycemia de-
velops, reaching 3 cycles or lees as coma interv•nas. Normal rhythm 
is restored by the intravenmus~infusion of glucose. Himwich and 
associates (42) have demonstrated a direct relationship between the 
frequency of alpha waves and cerebral oxygen consumption. Both dec-
line in hypoglycemia and increase after carbohydrate administration. 
" The delta index is inversely related because it 1e augmented during 
decreased oxygen utilization by the brain. The EEG appears, then, 
to be non-specific, but highly suggestive, especially if the abnor-
malities present disappear on glucose administration. 
Theusefulness of a high protein, low carbohydrate diet in com-
bating the symptoms of functional hypoglycemia is based on the fact 
that about one-half of the protein~ by gluconeogenesis, is yielded 
as glucose over an extended period of time (20). It obviates the 
strong carbohy,Ldrate stimulus to insllllin production, thereby reduc-
ing the likelihood of a reactive oversecretion. The diet is used as 
a method of excluding functional hyperinsulinism. 
Perhaps the most appealing technique of diagnosis is the mea-
surement of blood-insulin levels. Kelley (50) reports that in 1953 
Willebrands and Groen obtained higher values than normal in 4 pa-
tients with an insulinoma confirmed by surgery. After excision of 
these tumors blood-insulin levels returned to normal. There are 
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two principle methods of measuring insulin, viz. an in~vivo method 
using alloxan-diabetic, hypophysectomized, adrenalectomized rate (10) 
and an in vitro method utilizing the fact that a quantitative rela-
tionship exists between the amount of insulin present in the buffer 
solution and the disappearance of glucose from that solution in the 
presence of rat diaphragm, the glycogen content of which increases 
proportionately as well. In 1954, Vallance-Owen and Hurlock (87) 
tested healthy young men using this method and obtained fasting levels 
of 31-82 microunita per milliliter. In a case presented by ~alley (50) 
a 33 year old man with a typical history had 300 microunits per milli-
liter. The preoperative FBS was 53 milligrams per cent, significant 
because, although the patient was subsequently shown to have an insu-
linoma, he failed to meet one of the Whipple criteria. At the end of 
a 19-hour postoperative starvation (comparable to the preoperative 
starvation time), 50 microunits per milliliter were found. By getting 
direct plasma-insulin measurement, the variation in compensatory 
ability of different patients and consequently the differing levels 
of blood-glucose becomes unimportant. Ae in this case, with a 53 mil-
ligrams per cent determinatian, it can safely be ignored in the insu-
lin-assay results are abnormally high. The blood sample ia drawn in 
the fasting state, when functional hyperglycemia is not exhibited. 
The prasenceof an inadequate glycogen supply in the liver is not an 
influence except insofaras it might reduce the output of insulin by 
a tumor (assuming here that low blood eugar depresses the production 
of insulin by the tumor, an assumption for which no evidence has been 
collected). Altogether it is a good method, the only detracting fac-
~ tor being ita expense. 
Using Mirsky•s technique (60) for measuring insulin in urine, 
Willner and Weinstein (94) demonstrated an increla• of almost nine-
-19-
fold in the output of insulin in a patient harboring an insulinoma, 
the level returning to normal 2 weeks after removal of the tumor. 
More experience with this diagnostic technique will be required for 
evaluation. 
VII. DIFFERENTIAL DIAGNOSIS 
To attempt to make a diagnosis of organic hyperinsulinism on 
the basis of the neurological symptom is useless. As has been men-
tioned, too many entities mus~, be ruled out fir~t, while close at-
... • 
tention payed to the time relatlons of the episodes will be rewarded 
by an early diagnosis. Conn (24) gives the following classification 
of hypoglyc~mia-producing diseases: 
I. Organic 
A. Wyperinsuliniem 
l. Pancreatic islet cell adenoma 
2. Pancreatic islet cell carcinoma 
3. Diffuse hyperplasia of islet cells 
B. Hepatic disease 
l. Infectious cholangiol~tis 
2. Toxic hepatitis 
3. Diffuse hepatitis 
4. Fatty degeneration or metamorphosis 
5. Glycogenosis (von Gierke's) 
c. Pituitary hypofunction (anterior lobe) 
l. Destructive lesion (chromophobe tumor cyst) 
2. Atrophy and degeneration (Simmonds' disease) 
3. ~byroid hypofunction secondary to pituitary hypofunction 
D. AdrEmocortica l hypofunction (Addison's diseaae) 
l. Idiopathic cortical atrpphy 
2. Destructive infectious sanulomata 
3. Destructive neoplasm 
E. Central nervous lesions (hypothalamus) interference with 
nervous control of blood sugar 
II. Hypoglycemia without dawonetrable anatomic lesion 
A. Increased secretion of insulin by islet cells (? autono-
mic imbalance) 
B. Alimentary hypoglycemia 
l. Post-gastrectomy 
2. Post-gastroenterostomy 
a. Renal glycosuria 
D. Lactation 
E. severe continuous muscle work 
F. Poet-operative hypoglycemia 
G. Severe inanition 
H. Factitious 
I. Unknown 
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Most of the important causes are listed except idiopathic spontaneous 
hypoglycemi~ of infancy (58), a recently recognized entity which may 
simulate organic hyperinsulinism in every.respect. 
For all practical purposes one cannot differentiate between islet 
cell adenoma and islet cell carcinoma, although the more fulminant 
course and lower fasting blood sugar are more characteristic of the 
latter (24, 46). Hepatitides ought to give signs and symptoms referable 
to the liver. Pituitary hypofunction and adrenocortical hypofunction 
can be detected in the usual ways (Thorn's eosinophil test, blood and 
urine hormone assays, physical evidence, etc.) as can thyroid hypo-
function (radioactive iodine uptake, blood protein-bound iodine, basal 
metabolic rate). Central nervous system lesions may be somewhat more 
difficult to detect, especially if a lesion is localized to the hypo-
~ thalamus. In this connection, the deaths of two patients in hyper-
pyrexia and other states characteristic of hypothalamic dysfunction 
(75) suggests the possible involvement of this area in some cases of 
organic hyperinsulinism. 
"The finding of renal glycosuria in a patient having attacks of 
spontaneous hypoglycemia does not establish renal glycosuria as the 
cause. In liver disease glycosuria alternating with hypo3lycemia 
occurs. A dextrose tolerance test will differentiate the conditions." 
(21) 
Idiopathic spontaneous hypoglycemia of infancy (23, 58), which 
forces the clinician to take into account the age of appearance of 
an insulinoma-like syndrome before advising surgery, is characterized 
by severe fasting hypoglycemia without demonstrable organic lesion. 
It occurs during infancy and early childhood and subsides spontaneous-
ly as the child grows older. "In the active phase of the disturbance 
the clinical and laboratory findings are undistinguishable from those 
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observed in organic hyperinsulinism (23)." 
Functional hyperinsulinism ie colidinarily not as severe as the 
organic type. Fasting blood sugars are rarely more than 6 to 10 
$1ll1grama below those of normal individuals. A diet low in free 
sugar has produced definite clinical improvement. Psychotherapeutic 
and medical treatment should return the patient to near-normal statu~ 
(73). 
VIII. SEQUELAE 
Surgery as soon as possible after diagnosis has been urged. 
Several authors (24) have said this because (a) the patient may be-
come obese making surgery technically more difficult, (b) benign 
adenomas may become malignant, (c) the danger of irreversible mental 
deterioration is present and (d) there is the danger of an irrever-
sible episode ending in death. Obesity occurred in only 25 per cent 
of Crain and Thorn's series (24), benig~ adenomas have never been 
shown to become malignant (46) (although this might logically be 
hypothesized), but mental deterioration of an irreversible type and 
even death in hypoglycemia coma have been reported {67). 
In most cases, re~oval of the tumor results in total cessation 
of symptoms. Those which do not completely •~mver or who die in 
hypoglycemia exhibit central nervous system changes. Moersch and 
Kernahan {61) report the appearance of the brain of a 35 year old 
man. His brain showed marked edema with distention of the perivas-
cular spaces, clear spaces around all the nerve cells and acute 
swelling of the oligodendroglla. There was satellitosis and prac-
~ tically none of the cortical neuron• were normal or arranged in an 
orderly fashion. Degeneration of the nerve cells was the outstanding 
change. It varied from place to place. There was loss of the anterior 
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horn cells in a segment of the lumbar cord. 
Howard et al. (46) mention the finding of capillary engorgement, 
scattered hemorrhages, perivascular petechiae, acute degenerative 
changes in the nerve cells and secondary glial proliferation. At-
rophy of the cortex and basal ganglia, diffuse or localized, has been 
described. 
In the six brains seen by Lawrence and his colleagues (53), 
most affected were the cerebral cortex, caudate nucleus, and putamen, 
while the cerebellum was lees affected and the remaining brain cen-
ters only slightly. Degeneration of the anterior horn cells has 
been observed by Barr~s (4), Moersch and Kernahan {61), and Tom and 
Richardson (85). 
Muscular atrophy, in some cases comparable to that seen in prog-
ressive muscular atrophy has been described in 3 papers (4, 85, 94). 
Pickard, Kelter, and Rosenberg11~escribed the occurrence of a 
corOQary thromb~sis in the presence of a phase of excessive insulin 
secretion. 
Porter and Frantz (72) have the impression that deaths trom 
gastrointestinal bleeding may be slightly more prevalent among patients 
who hav~ had an insulinoma than in the general population. Four of 
their series of 40, followed for long periods of time died of this 
cause. This is an interesting observation in view of the existence 
of the syndrome of ulcerogenic non-functioning lslet cell adenoma 
Zollinger-Ellieon syndrome). 
Late peripheral paresis and dementia (67,.79) have resulted per-
manently from organic hyperinsulinism, although the incidence ot 
these serious sequelae is distinctly low and the prognosis for be-
nign adenomas is excellent. 
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IX. SURGERY 
Surgery is th~ only definitive ~ithod of treatment, although 
drug therapy is used to prepare a patient for surgery, in poor-risk 
patients, or in those refusing operation~ The results of surgery are 
excellent when benign tumors are present (46). Once the diagnosis 
is made, the surgeon prepares the patient by feeding a high protein 
diet, assessing the electrolyte situation with particular reference 
to potassium and phosphate, and improves glycogen reserves. Ether 
with constant intratracheal oxygeq in high concentration has been 
called the ideal anesthetic. Intr~venous glucose ia given befora 
surgery and continued until removal of the tu:ao.;o with careful fol-
lowing of the blood sugar level during surgery. After removal of' 
the tumor, it is generally found that the blood-sugar level tends to 
mount stteply (38). This is a good index of the success of the sur-
geon in removing tumor-bearing tissue. 
The surgeon often has difficulty in locating the tumor. A 
state of adenomatosis may not be evident and even large tumors b~ried 
in the head of the pancreas may not be felt. In this case most sur-
geons have elected to do a subtotal resection of the pancreas, taking 
the body and tail. The probability, accoraing to tne Howard analysis 
or distribution or tumors is '5 per cent that the tumor in any g1ven 
case will be in this specimen. However, this is not always the case, 
as is evidenced by tnose in which repeated operations, sometimes 
three or four times, going even to total pancreatectomy,are done. 
Holst's experience (4~) with 7 cases in 3 of wnich tne tumor was 
not obvious but, at second operations, were revealed by transection 
of the head of the pancreas, highlights this method as a possibility 
when the surgeon wants to make an attempt to expose tissue not readily 
available to the palpating finger. The tecnnica! difricul&ies are 
1 
-24-
large when cutting into the head of the pancreas, einca the duct of 
Wireung, common bile duct, and duodenum may all be embedded in the 
tissue. Although no reports were seen in which transection was used 
as a method of exploration, it would see~ logical and might spare 
the patient the need for excision of the head after removal of body 
and tall in previous surgery. The diabetes pursuant upon total 
pancreatectomy is not severe and is easily controllable (74). 
The overall mortality for operative removal of an adenoma was 
8.4 per cent in the Howard series (46). Seventy-nine and a h~lf per 
cent of patients undergoing removal of a tumor were relieved of their 
hypoglycemia. This figure is 87.3 per cent if one exculdes the opera-
tive mortalities. At least 4 patients experienced recurrence of hypo-
glycemia after initial relief following surgery. Excision of non-
tumor-bearing tissue does not appear to palliate the disease. 
Simple enucleation of the tumor was performed in 153 of the 
Howard series, of which 127 (86.4 per cent) were cured and 9.5 per 
cent died. Forty-three patients showed multiple tumors (12.6 per cent), 
of which most had two or three, showing the need for furthur explora-
tion even after one tumor has been located. 
Forty-eight patients had a subtotal resection for the removal 
of an adenoma and there appears to be no particular advantage in this 
procedure as opposed to simple enucleation. 
When no tumor has been palpable, 77 patients underwent subtotal 
resection of the pancreas in the hape of removing an occult tumor. 
About 43 per cent were cured with about 9 per cent being lmproyed. 
The operative mortality was 14.3 per cent. Since this time, however, 
operative mortality has probably been reduced by modern methods of 
treating shock, increased understanding of the metabolic changes that 
occur in surgery, etc. 
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The presence of an ectopic location for an insulinoma must al-
ways be kept in mind. Several cases in which this occurred have been 
cited {44, 68, 70). These may theoretically occur anywhere ectopic 
pancreatic tissue does, e.g. duodenum, stomach, jejunum, ileum, 
Meckel's diverticulum, and others. 
X. MEDICAL TREATMENT 
A. Alloxan 
Treatment of insulinoma by administration of alloxan has been 
of no avail in the few instances of its use. In experimental animals 
it appears to have a specific necrosing action on the beta cells of 
the islets, but this has proved to be no rationale for human use (27). 
The most encouraging report was that of only temporary improvement but 
~ no cure in a patient with islet cell carcinoma (13). Since there are 
other drugs to be used palliatively in carcinoma of the islets, it 
would seem unjustified to administer alloxan. The local side reac-
tions (32) and possible adverse parenchymatous changes brought about 
in the heart, liver, thyroid gland, and kidney tubules (27) would 
furthur militate against its use. In two instances it may actually 
have caused death (24, 32). It is mentioned only to be condemned. 
B. ACTH and Cortisone 
Five recent reports have indicated that ACTH and/or cortisone is 
of definite benefit in restoring the blood sugar to the normal range 
in patients with ineulinoma (5, 11, 17, 59, 83). Why t~e body does 
not react to a low blood sugar by compensatory increased output of 
endogenous corticoids remains enigmatic. There have been cases re-
ported in which adrenocortical tumors (1 carcinoma, 1 adenoma) co-
existed with insulinoma (24) and two in which diffuse adrenal hyper-
plasia was found at autopsy (25, 26). Whether these structural changes 
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repcesent a physiological attempt at compensation is only specula-
tion. Baumgartner and Reynolds (5) reported the case of a patient 
with metastatic disease who was sustained by ACTH gel for a year. 
c. Growth hormone 
Two reports exist in which growth hormone was used (7, 8). In 
general, it produced a decrease in the amount of sugar neceseary to 
prevent hypoglycemic attacks and some decrease in body weight. In 
one case it was said to have produced an increase in preprandial 
blood-sugar levels (8). Growth hormone tends to have less action 
in the same individual with repeated dosage, possibly because it ex-
cites antibody formation. 
D. ~!ucagon 
Glucagon has never been used in a case of insulinoma, although 
it probably will be sooner or later. A very recent article points 
out ita favorable effects in therapy of insulin reactions in dia-
be tic e ( 29 ) • 
E. Epinephrine 
Obviously, since epinephrine mobilizes liver glycogen and sti-
mulates the output of ACTH by the adenopypophyeis, it would tend to 
-produce a hyperglycemia and relive an attack of hyperinsulinism (90). 
F.~ 
The high-protein, low-carbohydrate diet is now generally agreed 
to be the most therapeutic for a patient with organic hyperinsulinism 
( 20), since, as has been pointed out, 50·-Per cent of the protein is 
f' yielded slowly as glucose and, by providing a relatively steady source, 
it does not stimulate the output of insulin excessively and thus tends 
to stabilize blood sugar levels. High carbohydrate diets, on the other 
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hand, while immediately raliev•ing the signa and symptoms of hypogly-
cemia, actually are a stimulus to insulin output and may cause its 
subsequent high amount to throw the patient into another reaction. It 
also provokes the typical 3-4 hours, poet-prandial functional hyper-
insulinism attacks. 
XI • SUMMARY 
The significant literature related to the nature and treat~ent 
of insulin-secreting tumors of the islets of Langerhans has been re-
viewed. The differentiation between benign and malignant is diffi-
cult or impossible histologically unless metastases have been demon-
strated. The production of neurological symptoms appears to be re-
lated to interference of hypoglycemia with brain metaboleim by re-
" ducing its ability to utilize oxygen. The most important clue to 
diagnosis is the periodic pattern of attacks of a neurologic, gastro-
intestinal, or cardiovascular nature occurring at times when there 
is a tendency to reduced levels of blood-glucose, i.e. before break-
fast, when meals are skipped, and during strenuous exercise. Many 
other conditione must be differentiated but can usually be easily 
ruled out. The important1hing is to suspect insulinoma, since diag-
noetic tragedies can and have ensued when it has not been considered 
and investigated. The results of surgery have been very good and ir-
reversible brain pathology may be prevented with early treatment. 
ACTH and cortisone are useful for palliation of symptoms. 
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